Last 12 months
Inside the activity.
0 purchase rows · 34 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 5 |
| Feb 2026 | 0 | 5 |
| Mar 2026 | 0 | 2 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 11 |
| Jul 2026 | 0 | 5 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 16, 2020 Filed Mar 18, 2020 20:38 UTC |
CARR EDWARDChief Accounting Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 51,081 | $0.00 Strike: $1.45 | $0.00 |
DisclosureSEC source: 0001493152-20-004256 · ownership.xml · derivative · entry 1 CARR EDWARD · CIK 0001273351 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,081 Underlying: Common Stock · 51,081 shares Expires 2030-03-16 F2 · security: Contingent upon stockholder approval of an amendment to the 2015 Equity Incentive Plan (the "2015 Plan") at the Annual Meeting of Stockholders scheduled for May 20, 2020 to increase the number of shares available under the 2015 Plan, Mr. Carr will also be entitled to an additional grant of 28,919 stock options and a grant of 40,000 shares of restricted stock as soon as practicable after the amendment of the 2015 Plan. The stock options contingent upon stockholder approval will have an exercise price determined at the grant date. F1 · derivative.exercise_date: The options will vest 25% on March 16, 2021, and in 36 equal monthly installments thereafter. Read SEC document |
| March 16, 2020 Filed Mar 18, 2020 20:36 UTC |
Rouhandeh Steven HDirector · Executive Chairman · 10% owner
|
GrantEmployee Stock Option (right to buy) · Derivative | 153,244 | $0.00 Strike: $1.45 | $0.00 |
DisclosureSEC source: 0001493152-20-004255 · ownership.xml · derivative · entry 1 Rouhandeh Steven H · CIK 0001294343 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 153,244 Underlying: Common Stock · 153,244 shares Expires 2030-03-16 F2 · security: Contingent upon stockholder approval of an amendment to the 2015 Equity Incentive Plan (the "2015 Plan") at the Annual Meeting of Stockholders scheduled for May 20, 2020 to increase the number of shares available under the 2015 Plan, Mr. Rouhandeh will also be entitled to an additional grant of 86,756 stock options and a grant of 120,000 shares of restricted stock as soon as practicable after the amendment of the 2015 Plan. The stock options contingent upon stockholder approval will have an exercise price determined at the grant date. F1 · derivative.exercise_date: The awards will vest 25% on March 16, 2021, and in 36 equal monthly installments thereafter. Read SEC document |
| March 16, 2020 Filed Mar 18, 2020 20:35 UTC |
Silverstein Christine BerniDirector · Chief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 102,163 | $0.00 Strike: $1.45 | $0.00 |
DisclosureSEC source: 0001493152-20-004254 · ownership.xml · derivative · entry 1 Silverstein Christine Berni · CIK 0001772546 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,163 Underlying: Common Stock · 102,163 shares Expires 2030-03-16 F2 · security: Contingent upon stockholder approval of an amendment to the 2015 Equity Incentive Plan (the "2015 Plan") at the Annual Meeting of Stockholders scheduled for May 20, 2020 to increase the number of shares available under the 2015 Plan, Ms. Silverstein will also be entitled to an additional grant of 57,837 stock options and a grant of 80,000 shares of restricted stock as soon as practicable after the amendment of the 2015 Plan. The stock options contingent upon stockholder approval will have an exercise price determined at the grant date. F1 · derivative.exercise_date: The options will vest 25% on March 16, 2021, and in 36 equal monthly installments thereafter. Read SEC document |
| March 16, 2020 Filed Mar 18, 2020 20:34 UTC |
Siffert Joao MDDirector · Chief Executive Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 127,704 | $0.00 Strike: $1.45 | $0.00 |
DisclosureSEC source: 0001493152-20-004252 · ownership.xml · derivative · entry 1 Siffert Joao MD · CIK 0001534986 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,704 Underlying: Common Stock · 127,704 shares Expires 2030-03-16 F2 · security: Contingent upon stockholder approval of an amendment to the 2015 Equity Incentive Plan (the "2015 Plan") at the Annual Meeting of Stockholders scheduled for May 20, 2020 to increase the number of shares available under the 2015 Plan, Mr. Siffert will also be entitled to an additional grant of 72,296 stock options and a grant of 100,000 shares of restricted stock as soon as practicable after the amendment of the 2015 Plan. The stock options contingent upon stockholder approval will have an exercise price determined at the grant date. F1 · derivative.exercise_date: The options will vest 25% on March 16, 2021, and in 36 equal monthly installments thereafter. Read SEC document |
| December 24, 2019 Filed Dec 31, 2019 22:17 UTC |
Buono StefanoDirector
|
PurchaseCommon stock | 200,000 | $2.50 | $500,000.00 |
DisclosureSEC source: 0001493152-19-019948 · ownership.xml · nonDerivative · entry 1 Buono Stefano · CIK 0001665113 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 270,000 Read SEC document |
| September 12, 2019 Filed Sep 16, 2019 21:51 UTC |
CARR EDWARDChief Accounting Officer
|
GrantAbeona Therapeutics Inc. Common Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-19-044759 · tv529533_4.xml · nonDerivative · entry 1 CARR EDWARD · CIK 0001273351 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 F1 · security: The award was granted under the Abeona Therapeutics Inc. Equity Incentive Plan and will vest 100% on March 12, 2020. Read SEC document |
| May 21, 2019 Filed May 23, 2019 22:28 UTC |
Buono StefanoDirector
|
GrantStock Option (right to buy) · Derivative | 19,827 | $0.00 Strike: $7.42 | $0.00 |
DisclosureSEC source: 0001144204-19-028030 · tv522356_4.xml · derivative · entry 1 Buono Stefano · CIK 0001665113 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,827 Underlying: Common stock · 19,827 shares Expires 2029-05-21 Read SEC document |
| May 21, 2019 Filed May 24, 2019 00:34 UTC |
Alvino MarkDirector
|
GrantStock Option (right to buy) · Derivative | 19,827 | $0.00 Strike: $7.42 | $0.00 |
DisclosureSEC source: 0001144204-19-028043 · tv522351_4.xml · derivative · entry 1 Alvino Mark · CIK 0001356828 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,827 Underlying: Common stock · 19,827 shares Expires 2029-05-21 Read SEC document |
| May 21, 2019 Filed May 23, 2019 22:27 UTC |
Howell Stephen B.Director
|
GrantStock Option (right to buy) · Derivative | 19,827 | $0.00 Strike: $7.42 | $0.00 |
DisclosureSEC source: 0001144204-19-028029 · tv522354_4.xml · derivative · entry 1 Howell Stephen B. · CIK 0001464306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,827 Underlying: Common stock · 19,827 shares Expires 2029-05-21 Read SEC document |
| May 21, 2019 Filed May 23, 2019 22:25 UTC |
Wider ToddDirector
|
GrantStock Option (right to buy) · Derivative | 19,827 | $0.00 Strike: $7.42 | $0.00 |
DisclosureSEC source: 0001144204-19-028027 · tv522353_4.xml · derivative · entry 1 Wider Todd · CIK 0001642715 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,827 Underlying: Common stock · 19,827 shares Expires 2029-05-21 Read SEC document |
| May 21, 2019 Filed May 23, 2019 22:23 UTC |
Van Duyne Richard BDirector
|
GrantStock Option (right to buy) · Derivative | 19,827 | $0.00 Strike: $7.42 | $0.00 |
DisclosureSEC source: 0001144204-19-028025 · tv522350_4.xml · derivative · entry 1 Van Duyne Richard B · CIK 0001741345 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,827 Underlying: Common stock · 19,827 shares Expires 2029-05-21 Read SEC document |
| April 11, 2019 Filed Apr 12, 2019 14:20 UTC |
Buono StefanoDirector
|
PurchaseCommon stock | 49,020 | $7.91 | $387,978.59 |
DisclosureSEC source: 0001144204-19-019439 · tv518835_form4.xml · nonDerivative · entry 2 Buono Stefano · CIK 0001665113 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 Read SEC document |
| April 10, 2019 Filed Apr 12, 2019 14:20 UTC |
Buono StefanoDirector
|
PurchaseCommon stock | 20,980 | $7.54 | $158,271.02 |
DisclosureSEC source: 0001144204-19-019439 · tv518835_form4.xml · nonDerivative · entry 1 Buono Stefano · CIK 0001665113 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,980 Read SEC document |
| April 09, 2019 Filed Apr 11, 2019 23:06 UTC |
Rouhandeh Steven HDirector · Executive Chairman · 10% owner
|
GrantEmployee Stock Option (right to buy) · Derivative | 120,000 | $0.00 Strike: $7.24 | $0.00 |
DisclosureSEC source: 0001144204-19-019359 · tv518749_4.xml · derivative · entry 1 Rouhandeh Steven H · CIK 0001294343 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,000 Underlying: Common Stock · 120,000 shares Expires 2029-04-09 F1 · derivative.exercise_date: The options will vest 25% on April 9, 2020, and in 36 equal monthly installments thereafter. Read SEC document |
| April 09, 2019 Filed Apr 11, 2019 23:00 UTC |
Miller Timothy JSee Remarks
|
GrantEmployee Stock Option (right to buy) · Derivative | 72,000 | $0.00 Strike: $7.24 | $0.00 |
DisclosureSEC source: 0001144204-19-019356 · tv518747_4.xml · derivative · entry 1 Miller Timothy J · CIK 0001692659 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,000 Underlying: Common Stock · 72,000 shares Expires 2029-04-09 F1 · derivative.exercise_date: The options will vest 25% on April 9, 2020, and in 36 equal monthly installments thereafter. Read SEC document |
| April 09, 2019 Filed Apr 11, 2019 22:54 UTC |
Siffert Joao MDDirector · Chief Executive Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 100,000 | $0.00 Strike: $7.24 | $0.00 |
DisclosureSEC source: 0001144204-19-019351 · tv518744_4.xml · derivative · entry 1 Siffert Joao MD · CIK 0001534986 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2029-04-09 F1 · derivative.exercise_date: The options will vest 25% on April 9, 2020, and in 36 equal monthly installments thereafter. Read SEC document |
| April 09, 2019 Filed Apr 11, 2019 22:57 UTC |
CARR EDWARDChief Accounting Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $7.24 | $0.00 |
DisclosureSEC source: 0001144204-19-019353 · tv518745_4.xml · derivative · entry 1 CARR EDWARD · CIK 0001273351 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2029-04-09 F1 · derivative.exercise_date: The options will vest 25% on April 9, 2020, and in 36 equal monthly installments thereafter. Read SEC document |
| April 09, 2019 Filed Apr 11, 2019 22:52 UTC |
Silverstein Christine BerniChief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 80,000 | $0.00 Strike: $7.24 | $0.00 |
DisclosureSEC source: 0001144204-19-019348 · tv518743_4.xml · derivative · entry 1 Silverstein Christine Berni · CIK 0001772546 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires 2029-04-09 F1 · derivative.exercise_date: The options will vest 25% on April 9, 2020, and in 36 equal monthly installments thereafter. Read SEC document |
| April 08, 2019 Filed Apr 10, 2019 22:39 UTC |
Howell Stephen B.Director
|
PurchaseCommon stock | 4,000 | $7.77 | $31,080.00 |
DisclosureSEC source: 0001144204-19-019115 · tv518674_form4.xml · nonDerivative · entry 1 Howell Stephen B. · CIK 0001464306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,494 F1 · balance_after: The reporting person has been delinquent in his Section 16 reporting and will file outstanding reports as soon as reasonably practicable. The amount reported in this Column 5 accounts for all prior transactions in the Issuer's common stock that have not been reported. Read SEC document |
| April 08, 2019 Filed Apr 18, 2019 21:57 UTC |
Van Duyne Richard BDirector
|
PurchaseCommon stock | 6,000 | $7.71 | $46,260.00 |
DisclosureSEC source: 0001144204-19-020318 · tv519212_form4.xml · nonDerivative · entry 1 Van Duyne Richard B · CIK 0001741345 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Read SEC document |
| February 11, 2019 Filed Apr 18, 2019 21:58 UTC |
Siffert Joao MDDirector · Chief Executive Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 110,000 | $0.00 Strike: $6.70 | $0.00 |
DisclosureSEC source: 0001144204-19-020317 · tv519202_4.xml · derivative · entry 2 Siffert Joao MD · CIK 0001534986 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,000 Underlying: Common Stock · 110,000 shares Expires 2029-02-11 F2 · derivative.exercise_date: The options will vest 25% on February 11, 2020, and in 36 equal monthly installments thereafter. Read SEC document |
| January 31, 2019 Filed Apr 18, 2019 21:58 UTC |
Siffert Joao MDDirector · Chief Executive Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 60,000 | $0.00 Strike: $6.59 | $0.00 |
DisclosureSEC source: 0001144204-19-020317 · tv519202_4.xml · derivative · entry 1 Siffert Joao MD · CIK 0001534986 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2029-01-31 F1 · derivative.exercise_date: The options will vest 25% on January 31, 2020, and in 36 equal monthly installments thereafter. Read SEC document |
| January 07, 2019 Filed Apr 18, 2019 21:58 UTC |
Silverstein Christine BerniChief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $7.02 | $0.00 |
DisclosureSEC source: 0001144204-19-020316 · tv519201_4.xml · derivative · entry 1 Silverstein Christine Berni · CIK 0001772546 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2029-01-07 F1 · derivative.exercise_date: The options will vest 25% on January 7, 2020, and in 36 equal monthly installments thereafter. Read SEC document |
| November 19, 2018 Filed Apr 18, 2019 21:57 UTC |
CARR EDWARDChief Accounting Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 35,000 | $0.00 Strike: $8.54 | $0.00 |
DisclosureSEC source: 0001144204-19-020315 · tv519200_4.xml · derivative · entry 1 CARR EDWARD · CIK 0001273351 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2028-11-19 F1 · derivative.exercise_date: The options will vest 25% on November 19, 2019, and in 36 equal monthly installments thereafter. Read SEC document |
| May 22, 2018 Filed May 23, 2018 23:24 UTC |
Van Duyne Richard BDirector
|
GrantStock option (right to buy) · Derivative | 30,000 | $0.00 Strike: $16.02 | $0.00 |
DisclosureSEC source: 0000318306-18-000005 · primary_doc.xml · derivative · entry 1 Van Duyne Richard B · CIK 0001741345 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common stock · 30,000 shares Expires 2028-05-22 F1 · shares: 100% accelerated vesting on change of control. Read SEC document |
| May 22, 2018 Filed May 23, 2018 23:32 UTC |
Buono StefanoDirector
|
GrantStock option (right to buy) · Derivative | 30,000 | $0.00 Strike: $16.02 | $0.00 |
DisclosureSEC source: 0000318306-18-000006 · primary_doc.xml · derivative · entry 1 Buono Stefano · CIK 0001665113 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common stock · 30,000 shares Expires 2018-05-22 F1 · shares: 100% accelerated vesting on change of control. Read SEC document |
| March 29, 2018 Filed Apr 3, 2018 00:35 UTC |
Thiel CarstenChief Executive Officer
|
GrantStock option (right to buy) · Derivative | 262,500 | $0.00 Strike: $13.65 | $0.00 |
DisclosureSEC source: 0000318306-18-000002 · primary_doc.xml · derivative · entry 2 Thiel Carsten · CIK 0001633582 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 262,500 Underlying: Common stock · 262,500 shares Expires 2028-03-29 F1 · shares: 100% accelerated vesting on change of control F2 · derivative.exercise_date: After twelve months from the Grant Date options vest 2.0833% monthly. All options vested 48 months from Grant Date. Read SEC document |
| March 29, 2018 Filed Apr 3, 2018 00:35 UTC |
Thiel CarstenChief Executive Officer
|
GrantStock option (right to buy) · Derivative | 87,500 | $0.00 Strike: $13.65 | $0.00 |
DisclosureSEC source: 0000318306-18-000002 · primary_doc.xml · derivative · entry 1 Thiel Carsten · CIK 0001633582 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,500 Underlying: Common stock · 87,500 shares Expires 2028-03-29 F1 · shares: 100% accelerated vesting on change of control Read SEC document |
| December 14, 2017 Filed Dec 18, 2017 22:26 UTC |
THOMPSON STEPHEN BSr VP Finance
|
GrantStock option (right to buy) · Derivative | 18,750 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0000318306-17-000006 · primary_doc.xml · derivative · entry 2 THOMPSON STEPHEN B · CIK 0001182768 · Sr VP Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,750 Underlying: Common stock · 18,750 shares Expires 2027-12-14 F1 · shares: 100% accelerated vesting on change of control. F2 · derivative.exercise_date: After twelve months from the Grant Date options vest 2.0833% monthly. All options vested 48 months from Grant Date. Read SEC document |
| December 14, 2017 Filed Dec 18, 2017 22:26 UTC |
THOMPSON STEPHEN BSr VP Finance
|
GrantStock option (right to buy) · Derivative | 6,250 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0000318306-17-000006 · primary_doc.xml · derivative · entry 1 THOMPSON STEPHEN B · CIK 0001182768 · Sr VP Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,250 Underlying: Common stock · 6,250 shares Expires 2027-12-14 F1 · shares: 100% accelerated vesting on change of control. Read SEC document |
| December 14, 2017 Filed Dec 18, 2017 22:14 UTC |
Alvino MarkDirector
|
GrantStock option (right to buy) · Derivative | 30,000 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0000318306-17-000005 · primary_doc.xml · derivative · entry 1 Alvino Mark · CIK 0001356828 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common stock · 30,000 shares Expires 2027-12-14 F1 · shares: 100% accelerated vesting on change of control. Read SEC document |
| December 14, 2017 Filed Dec 18, 2017 22:04 UTC |
Wider ToddDirector
|
GrantStock option (right to buy) · Derivative | 30,000 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0000318306-17-000004 · primary_doc.xml · derivative · entry 1 Wider Todd · CIK 0001642715 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common stock · 30,000 shares Expires 2027-12-14 F1 · shares: 100% accelerated vesting on change of control. Read SEC document |
| December 14, 2017 Filed Dec 18, 2017 21:48 UTC |
Miller Timothy JDirector · President & CEO
|
GrantStock option (right to buy) · Derivative | 67,500 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0000318306-17-000003 · primary_doc.xml · derivative · entry 2 Miller Timothy J · CIK 0001692659 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,500 Underlying: Common stock · 67,500 shares Expires 2027-12-14 F1 · shares: 100% accelerated vesting on change of control. F2 · derivative.exercise_date: After twelve months from Grant Date options vest 2.0833% monthly. All options vested 48 months from Grant Date. Read SEC document |
| December 14, 2017 Filed Dec 18, 2017 21:48 UTC |
Miller Timothy JDirector · President & CEO
|
GrantStock option (right to buy) · Derivative | 22,500 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0000318306-17-000003 · primary_doc.xml · derivative · entry 1 Miller Timothy J · CIK 0001692659 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,500 Underlying: Common stock · 22,500 shares Expires 2027-12-14 F1 · shares: 100% accelerated vesting on change of control. Read SEC document |
| December 14, 2017 Filed Dec 18, 2017 21:32 UTC | GrantStock option (right to buy) · Derivative | 60,000 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0000318306-17-000002 · primary_doc.xml · derivative · entry 2 Jeffrey B Davis · CIK 0001349083 · COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common stock · 60,000 shares Expires 2027-12-14 F1 · shares: 100% accelerated vesting on change of control. F2 · derivative.exercise_date: After twelve months from the Grant Date option vest 2.0833% monthly. All options vested 48 months from Grant Date. Read SEC document |
|
| December 14, 2017 Filed Dec 18, 2017 21:32 UTC | GrantStock option (right to buy) · Derivative | 20,000 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0000318306-17-000002 · primary_doc.xml · derivative · entry 1 Jeffrey B Davis · CIK 0001349083 · COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common stock · 20,000 shares Expires 2027-12-14 F1 · shares: 100% accelerated vesting on change of control. Read SEC document |
|
| December 14, 2017 Filed Dec 18, 2017 21:16 UTC |
Rouhandeh Steven HDirector · Executive Chairman · 10% owner
|
GrantStock option (right to buy) · Derivative | 90,000 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0000318306-17-000001 · primary_doc.xml · derivative · entry 2 Rouhandeh Steven H · CIK 0001294343 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,000 Underlying: Common stock · 90,000 shares Expires 2027-12-14 F1 · shares: 100% accelerated vesting on change of control. F2 · derivative.exercise_date: After twelve months from the Grant Date options vest 2.0833% monthly. All options vested 48 months from Grant Date. Read SEC document |
| December 14, 2017 Filed Dec 18, 2017 21:16 UTC |
Rouhandeh Steven HDirector · Executive Chairman · 10% owner
|
GrantSrock option (right to buy) · Derivative | 30,000 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0000318306-17-000001 · primary_doc.xml · derivative · entry 1 Rouhandeh Steven H · CIK 0001294343 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common stock · 30,000 shares Expires 2027-12-14 F1 · shares: 100% accelerated vesting on change of control. Read SEC document |
| December 14, 2017 Filed May 22, 2019 21:10 UTC |
Howell Stephen B.Director
|
GrantStock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0001144204-19-027766 · tv522178_4.xml · derivative · entry 13 Howell Stephen B. · CIK 0001464306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common stock · 30,000 shares Expires 2027-12-14 F2 · derivative.exercise_date: Vests 100% six months after grant date. Read SEC document |
| December 13, 2016 Filed Dec 16, 2016 01:34 UTC |
THOMPSON STEPHEN BVP Finance-Chief Acctg Officer
|
GrantStock option (right to buy) · Derivative | 18,750 | $0.00 Strike: $4.45 | $0.00 |
DisclosureSEC source: 0000318306-16-000055 · primary_doc.xml · derivative · entry 2 THOMPSON STEPHEN B · CIK 0001182768 · VP Finance-Chief Acctg Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common stock · 18,750 shares Expires 2026-12-13 F1 · shares: 100% accelerated vesting on change of control. F2 · derivative.exercise_date: After twelve months from Grant Date options vest 2.0833% monthly. All options vested 48 months from Grant Date. Read SEC document |
| December 13, 2016 Filed Dec 16, 2016 01:34 UTC |
THOMPSON STEPHEN BVP Finance-Chief Acctg Officer
|
GrantStock option right to buy) · Derivative | 6,250 | $0.00 Strike: $4.45 | $0.00 |
DisclosureSEC source: 0000318306-16-000055 · primary_doc.xml · derivative · entry 1 THOMPSON STEPHEN B · CIK 0001182768 · VP Finance-Chief Acctg Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,250 Underlying: Common stock · 6,250 shares Expires 2026-12-13 F1 · shares: 100% accelerated vesting on change of control. Read SEC document |
| December 13, 2016 Filed Dec 16, 2016 01:18 UTC |
Wider ToddDirector
|
GrantStock option (right to buy) · Derivative | 50,000 | $0.00 Strike: $4.45 | $0.00 |
DisclosureSEC source: 0000318306-16-000054 · primary_doc.xml · derivative · entry 1 Wider Todd · CIK 0001642715 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common stock · 50,000 shares Expires 2026-12-13 F1 · shares: 100% accelerated vesting on change of control. Read SEC document |
| December 13, 2016 Filed Dec 16, 2016 01:07 UTC |
Alvino MarkDirector
|
GrantStock option (right to buy) · Derivative | 50,000 | $0.00 Strike: $4.45 | $0.00 |
DisclosureSEC source: 0000318306-16-000053 · primary_doc.xml · derivative · entry 1 Alvino Mark · CIK 0001356828 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common stock · 50,000 shares Expires 2026-12-13 F1 · shares: 100% accelerated vesting on change of control. Read SEC document |
| December 13, 2016 Filed Dec 16, 2016 00:48 UTC |
Jeffrey B DavisDirector · Chief Operating Officer
|
GrantStock option (right to buy) · Derivative | 112,500 | $0.00 Strike: $4.45 | $0.00 |
DisclosureSEC source: 0000318306-16-000051 · primary_doc.xml · derivative · entry 2 Jeffrey B Davis · CIK 0001349083 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common stock · 112,500 shares Expires 2026-12-13 F1 · shares: 100% accelerated vesting on change of control. F2 · derivative.exercise_date: After twelve months from Grant Date options vest 2.0833% monthly. All options vested 48 months from Grant Date. Read SEC document |
| December 13, 2016 Filed Dec 16, 2016 00:48 UTC |
Jeffrey B DavisDirector · Chief Operating Officer
|
GrantStock option (right to buy) · Derivative | 37,500 | $0.00 Strike: $4.45 | $0.00 |
DisclosureSEC source: 0000318306-16-000051 · primary_doc.xml · derivative · entry 1 Jeffrey B Davis · CIK 0001349083 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,500 Underlying: Common stock · 37,500 shares Expires 2026-12-13 F1 · shares: 100% accelerated vesting on change of control. Read SEC document |
| December 13, 2016 Filed Dec 16, 2016 00:59 UTC |
Ahn Mark JDirector
|
GrantStock option (right to buy) · Derivative | 150,000 | $0.00 Strike: $4.45 | $0.00 |
DisclosureSEC source: 0000318306-16-000052 · primary_doc.xml · derivative · entry 1 Ahn Mark J · CIK 0001296543 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common stock · 150,000 shares Expires 2026-12-13 F1 · shares: 100% accelerated vesting on change of control. Read SEC document |
| December 13, 2016 Filed Dec 16, 2016 00:36 UTC |
Rouhandeh Steven HDirector · Executive Chairman · 10% owner
|
GrantStock option (right to buy) · Derivative | 150,000 | $0.00 Strike: $4.45 | $0.00 |
DisclosureSEC source: 0000318306-16-000050 · primary_doc.xml · derivative · entry 2 Rouhandeh Steven H · CIK 0001294343 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common stock · 150,000 shares Expires 2026-12-13 F1 · shares: 100% accelerated vesting on change of control. F2 · derivative.exercise_date: After twelve months from Grant Date options vest 2.0833% monthly. All options vested 48 months from Grant Date. Read SEC document |
| December 13, 2016 Filed Dec 16, 2016 00:36 UTC |
Rouhandeh Steven HDirector · Executive Chairman · 10% owner
|
GrantStock option (right to buy) · Derivative | 50,000 | $0.00 Strike: $4.45 | $0.00 |
DisclosureSEC source: 0000318306-16-000050 · primary_doc.xml · derivative · entry 1 Rouhandeh Steven H · CIK 0001294343 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common stock · 50,000 shares Expires 2026-12-13 F1 · shares: 100% accelerated vesting on change of control. Read SEC document |
| December 13, 2016 Filed May 22, 2019 21:10 UTC |
Howell Stephen B.Director
|
GrantStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $4.45 | $0.00 |
DisclosureSEC source: 0001144204-19-027766 · tv522178_4.xml · derivative · entry 12 Howell Stephen B. · CIK 0001464306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common stock · 50,000 shares Expires 2026-12-13 F2 · derivative.exercise_date: Vests 100% six months after grant date. Read SEC document |
| November 08, 2016 Filed Nov 9, 2016 21:56 UTC |
Ahn Mark JDirector
|
Exercise / conversionStock option (right to buy) · Derivative | 150,000 | $2.31 Strike: $2.31 | $346,500.00 |
DisclosureSEC source: 0000318306-16-000048 · primary_doc.xml · derivative · entry 2 Ahn Mark J · CIK 0001296543 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 150,000 shares Expires 2026-02-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.